创伤出血时输注血小板降低纤溶但不恢复血小板功能
研究纳入2008年1月至2015年11月前瞻性ACTIVATION of Coagulation and Inflammation in Trauma研究中接受至少4单位浓缩红细胞(PRBC)的创伤患者,于急诊科伤后2小时内及每输注4单位PRBC后抽血,用多电极聚集仪测全血血小板聚集、酶联免疫吸附法测血浆蛋白。161例接受4单位及以上PRBC的患者中,44例接受8–11单位、28例接受12单位及以上;各时间点接受血小板输注者与仅接受其他血制品者血小板聚集相似(所有时间点P>0.05)。每4单位PRBC区间内输注血小板与旋转血栓弹力图最大溶解百分比下降(区间开始6%[2-12] vs 区间结束2%[0-5],P=0.001)、纤溶酶原激活物抑制剂-1升高(35.9±14.9 vs 66.7±22.0,P=0.007)、组织型纤溶酶原激活物下降(26.2±10.5 vs 19.0±5.1,P=0.04)相关;不含血小板的区间这些参数无统计学显著变化。作者认为当前止血复苏策略似乎不能恢复活动性出血期间的血小板聚集,但储存血小板可能通过提供额外的纤溶酶原激活物抑制剂-1来源减轻纤溶,需进一步研究早期血小板输注对出血期间血小板功能、止血和临床结局的影响。
要点
- 创伤活动性出血各时间点,接受血小板输注者与仅接受其他血制品者血小板聚集相似(所有时间点P>0.05)。
- 每4单位PRBC区间内输注血小板与最大溶解百分比下降相关:区间开始6%(2-12)vs 区间结束2%(0-5),P=0.001。
- 输注血小板区间纤溶酶原激活物抑制剂-1由35.9±14.9升至66.7±22.0(P=0.007),组织型纤溶酶原激活物由26.2±10.5降至19.0±5.1(P=0.04)。
- 不含血小板的区间上述纤溶指标无统计学显著变化。
- 作者认为储存血小板可能通过提供纤溶酶原激活物抑制剂-1减轻纤溶,需进一步研究早期血小板输注的影响。
适用人群与场景
- 前瞻性ACTIVATION of Coagulation and Inflammation in Trauma研究中2008年1月至2015年11月纳入、接受至少4单位浓缩红细胞(PRBC)的创伤患者。
- 161例接受4单位及以上PRBC作为初始复苏一部分,其中44例接受8–11单位、28例接受12单位及以上。
研究设计与关键结果
- 研究类型为前瞻性观察研究(ACTIVATION of Coagulation and Inflammation in Trauma研究),纳入2008年1月至2015年11月接受至少4单位PRBC的创伤患者161例;于急诊科伤后2小时内及每输注4单位PRBC后抽血,用多电极聚集仪测全血血小板聚集、酶联免疫吸附法测血浆蛋白。
- 各时间点接受血小板输注者与仅接受其他血制品者血小板聚集相似(所有时间点P>0.05)。
- 每4单位PRBC区间内输注血小板与最大溶解百分比下降相关(区间开始6%[2-12] vs 区间结束2%[0-5],P=0.001)、纤溶酶原激活物抑制剂-1升高(35.9±14.9 vs 66.7±22.0,P=0.007)、组织型纤溶酶原激活物下降(26.2±10.5 vs 19.0±5.1,P=0.04)。
- 不含血小板的区间上述参数无统计学显著变化。
证据类型、等级与局限
- 证据类型:前瞻性观察研究;证据等级:治疗性,III级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为当前止血复苏策略似乎不能恢复活动性出血期间的血小板聚集,储存血小板可能通过提供纤溶酶原激活物抑制剂-1减轻纤溶。
- 作者认为需进一步研究早期血小板输注对出血期间血小板功能、止血和临床结局的影响。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Platelets play a critical role in hemostasis with aberrant function implicated in trauma-induced coagulopathy. However, the impact of massive transfusion protocols on platelet function during trauma hemorrhage is unknown. The aim of this study was to characterize the effects of platelet transfusion on platelet aggregation and fibrinolytic markers during hemostatic resuscitation.
METHODS: Trauma patients enrolled into the prospective Activation of Coagulation and Inflammation in Trauma study between January 2008 and November 2015 who received at least four units of packed red blood cells (PRBCs) were included. Blood was drawn in the emergency department within 2 hours of injury and at intervals after every four units of PRBCs transfused. Platelet aggregation was assessed in whole blood with multiple electrode aggregometry. Plasma proteins were quantified by enzyme-linked immunosorbent assay.
RESULTS: Of 161 patients who received four or more PRBCs as part of their initial resuscitation, 44 received 8 to 11 units and 28 received 12 units or more. At each timepoint during bleeding, platelet aggregation was similar in patients who had received a platelet transfusion compared with those who had only received other blood products (p > 0.05 for all timepoints). Platelet transfusion during the four PRBC intervals was associated with a decrease in maximum lysis on rotational thromboelastometry (start of interval, 6% [2-12] vs. end of interval, 2% [0-5]; p = 0.001), an increase in plasminogen activator inhibitor-1 (start of interval, 35.9 ± 14.9 vs. end of interval, 66.7 ± 22.0; p = 0.007) and a decrease in tissue plasminogen activator (start of interval, 26.2 ± 10.5 vs. end of interval, 19.0 +/- 5.1; p = 0.04). No statistically significant changes in these parameters occurred in intervals which did not contain platelets.
CONCLUSION: Current hemostatic resuscitation strategies do not appear to restore platelet aggregation during active hemorrhage. However, stored platelets may attenuate fibrinolysis by providing an additional source of plasminogen activator inhibitor-1. Further investigation into the effects of early platelet transfusion on platelet function, hemostatic, and clinical outcomes during bleeding are warranted.
LEVEL OF EVIDENCE: Therapeutic, level III.
参考来源
- Vulliamy P, Gillespie S, Gall LS, et al. Platelet transfusions reduce fibrinolysis but do not restore platelet function during trauma hemorrhage. J Trauma Acute Care Surg. 2017. PMID: 28452886. doi:10.1097/TA.0000000000001520
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。